CYTEK BIOSCIENCES DL-,001
CYTEK BIOSCIENCES DL-,001
Share · US23285D1090 · CTKB · A3CVW1 (XNAS)
Overview Financial Indicators
3,00 EUR
2,40 % 0,07 EUR
Frankfurt (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 22:30

Current Prices from CYTEK BIOSCIENCES DL-,001

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
CTKB
USD
06.06.2025 22:30
3,42 USD
3,34 USD
+2,40 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
-0,49 % 26,84 % -9,67 % -28,23 % -51,01 % -45,97 % -81,93 %

Company Profile for CYTEK BIOSCIENCES DL-,001 Share

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Company Data

Name CYTEK BIOSCIENCES DL-,001
Company Cytek Biosciences, Inc.
Symbol CTKB
Website https://cytekbio.com
Primary Exchange XNAS Frankfurt
WKN A3CVW1
ISIN US23285D1090
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Dr. Wenbin Jiang Ph.D.
Market Capitalization 468 Mio
Country United States of America
Currency EUR
Employees 0,6 T
Address 47215 Lakeview Boulevard, 94538 Fremont
IPO Date 2021-07-23

Ticker Symbols

Name Symbol
Frankfurt 8EQ.F
NASDAQ CTKB

More Shares

Investors who CYTEK BIOSCIENCES DL-,001 hold also have the following shares in their portfolio:
DMG MORI CO LTD
DMG MORI CO LTD Share
MANCHESTER BUILDING SOCIETY 6.75% PERM INTEREST BEARING SHS
MANCHESTER BUILDING SOCIETY 6.75% PERM INTEREST BEARING SHS Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025